The Conrad N. Hilton Foundation awarded a $750,000 grant to the Myelin Repair Foundation to fund myelin repair studies with human brain cells for the development of new treatments for multiple sclerosis. The funds will support research conducted by Paul Tesar, assistant professor of genetics, who focuses on the development of protocols to produce human oligodendrocyte precursor cells.

His work is part of the MRF’s overall strategy to build a comprehensive, non‐competitive translational medicine platform for evaluating all myelin repair targets identified in academic and industry laboratories.